v3.26.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
9 Months Ended
May 31, 2026
May 31, 2025
Operating Activities:    
Net income $ 128,948 $ 116,346
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 73,027 65,386
Loss on sale of property and equipment 1,027 1,579
Deferred income taxes (4,898) (953)
Equity in losses of unconsolidated affiliates 0 13
Gain on sale of joint venture (594) 0
Stock-based compensation 16,141 13,806
Change in operating assets and liabilities:    
Receivables, prepaid expenses and other current assets, non-current assets, accrued salaries and benefits, deferred membership income and other accruals (4,782) (9,329)
Merchandise inventories (62,322) (24,445)
Accounts payable 45,663 16,757
Net cash provided by operating activities 192,210 179,160
Investing Activities:    
Additions to property and equipment (144,074) (101,586)
Purchases of short-term investments (145,145) (72,255)
Proceeds from settlements of short-term investments 104,517 77,818
Purchases of long-term investments (11,870) 0
Proceeds from dissolution of investment in joint venture 1,057 0
Proceeds from disposal of property and equipment 6,461 235
Net cash used in investing activities (189,054) (95,788)
Financing Activities:    
Proceeds from long-term bank borrowings 20,837 5,441
Repayment of long-term bank borrowings (27,867) (32,742)
Proceeds from short-term bank borrowings 3,445 10,964
Repayment of short-term bank borrowings (12,624) (318)
Cash dividend payments (21,627) (19,376)
Purchase of treasury stock (8,915) (5,857)
Net cash used in financing activities (46,751) (41,888)
Effect of exchange rate changes on cash and cash equivalents and restricted cash 12,926 5,324
Net increase (decrease) in cash, cash equivalents and restricted cash (30,669) 46,808
Cash, cash equivalents and restricted cash at beginning of period 285,291 136,311
Cash, cash equivalents and restricted cash at end of period 254,622 183,119
Supplemental disclosure of noncash investing and financing activities:    
Capital expenditures accrued, but not yet paid 4,820 1,140
Dividends declared but not yet paid 21,683 19,411
Finance right-of-use assets obtained in exchange for lease liabilities 21,956 0
Operating right-of-use assets obtained in exchange for lease liabilities 17,557 20,378
Reconciliation of cash, cash equivalents, and restricted cash:    
Cash and cash equivalents 208,443 167,961
Short-term restricted cash 10,355 3,488
Long-term restricted cash 35,824 11,670
Total cash, cash equivalents, and restricted cash shown in the consolidated statements of cash flows $ 254,622 $ 183,119